Compounded Semaglutide Cost: Real Program Prices and the Post-Shortage Rules
What compounded semaglutide actually costs in 2026, how it compares to Wegovy and Ozempic, the current FDA rules after the shortage ended, and how to evaluate telehealth GLP-1 programs.
Compounded semaglutide is pharmacy-prepared medication containing the same active ingredient as Wegovy and Ozempic, sold through telehealth weight loss programs at $99-$227 per month versus roughly $1,349 list price for brand-name Wegovy. The clinical evidence behind the molecule is strong: the STEP 1 trial published in the New England Journal of Medicine in 2021 recorded 14.9% average body weight loss over 68 weeks on semaglutide 2.4mg. The regulatory ground shifted in 2025, though. The FDA declared the semaglutide shortage resolved in February 2025, which ended the legal basis for pharmacies to mass-produce copies of the brand drugs, and compounders moved to individually prescribed formulations that occupy a narrower legal lane. This guide covers what real programs charge in 2026, how compounded pricing compares to every branded route, and the specific questions that separate legitimate programs from risky ones.
Average Costs Comparison
Compounded semaglutide programs bundle medication, prescriber oversight, and shipping into one monthly price. Here is what real telehealth programs charge in 2026, alongside the branded comparison points:
| Provider | Monthly Cost | Per Dose | Consultation | Shipping | Notes |
|---|---|---|---|---|---|
| Strut Health | From $99/month | N/A (subscription) | Included | Free | Lowest-priced compounded semaglutide program in our comparison set |
| MEDVi | From $179/month | N/A (subscription) | Included | Free | GLP-1 program with intro pricing for the first month |
| TrimRx | From $179/month | N/A (subscription) | Included | Free | Compounded GLP-1 program with provider oversight |
| Sprout Health | From $199/month | N/A (subscription) | Included | Free | Compounded semaglutide program |
| SkinnyRx | From $199/month | N/A (subscription) | Included | Free | Compounded injectable semaglutide program |
| MyStart Health | From $222/month | N/A (subscription) | Included | Free | Compounded semaglutide with discount pricing available |
| Brand Wegovy (NovoCare self-pay) | $499/month | N/A | Requires outside prescription | Free | Manufacturer direct-to-patient channel for FDA-approved Wegovy |
| Brand Wegovy (retail pharmacy) | $1,300-$1,400/month | N/A | Requires outside prescription | N/A (pharmacy pickup) | Full list price; savings card reduces cost for covered commercial patients |
Detailed Price Breakdown by Provider
Strut Health
Strut Health anchors the low end of compounded semaglutide pricing at $99 per month, with prescriber consultation and shipping included. At roughly one-fifth the NovoCare self-pay price for brand Wegovy, this is the price point that makes GLP-1 treatment accessible for budgets that branded channels exclude.
MEDVi and TrimRx
MEDVi and TrimRx both start at $179 per month for compounded GLP-1 programs with provider oversight, refill management, and support included. Intro pricing may apply to the first month, so confirm the steady-state price and the dose escalation schedule before comparing against competitors.
Sprout Health, SkinnyRx, MyStart Health
The $199-$222 tier covers Sprout Health ($199), SkinnyRx ($199), and MyStart Health ($222). Programs in this tier compete on service depth: response time to messages, dose adjustment flexibility, and refill logistics. Since the medication is compounded semaglutide across the board, service quality and pharmacy sourcing are the real differentiators.
Brand Wegovy via NovoCare
Novo Nordisk sells Wegovy directly to self-pay patients through NovoCare Pharmacy at $499 per month for all doses, shipped free. This is the FDA-approved product from the original manufacturer at roughly one-third of retail list, and it is the benchmark any compounded program has to beat on price to justify the tradeoffs.
Insurance and Compounded Semaglutide
Insurance does not cover compounded semaglutide, full stop. Compounded medications are not FDA-approved products, so they sit outside formularies entirely. Insurance relevance here is indirect: if your plan covers brand Wegovy, the covered route with a savings card usually beats any compounded program on both price and product assurance, which makes checking coverage the mandatory first step before subscribing to anything.
Commercial Insurance
Coverage: Zero coverage for compounded; check brand coverage first
38% of large employer plans covered GLP-1s for weight loss in 2025 (Kaiser Family Foundation data). If yours does, covered Wegovy with the manufacturer savings card typically costs less than any compounded subscription.
Medicare / Medicaid
Coverage: Not covered
Medicare Part D excludes weight loss medications and never covers compounded products. State Medicaid programs likewise exclude compounded GLP-1s.
HSA / FSA
Coverage: Generally eligible with a prescription
Compounded semaglutide prescribed for weight management is typically a qualified medical expense. Request itemized receipts from your program for reimbursement.
Self-Pay
Coverage: N/A
This is the compounded market: $99-$227/month against $499 for NovoCare brand Wegovy and $1,300+ retail. The gap between compounded and NovoCare pricing narrowed in 2025, which changed the calculation for many buyers.
Compounded vs Brand Semaglutide Options
There is no FDA-approved generic semaglutide; patents run years longer. Your actual choice is between compounded preparations and three branded products containing the same molecule. The price-per-result math matters: every option below is backed by the same core molecule, but only the branded products carry FDA manufacturing oversight.
| Medication | Compounded/Generic | Brand-Name | Savings |
|---|---|---|---|
| Compounded semaglutide (telehealth programs) | $99-$227/month | N/A | 55-80% vs NovoCare; 85-92% vs retail Wegovy |
| Wegovy (weight loss label) | No generic exists | $499/month NovoCare; $1,300+ retail | NovoCare is 60%+ below retail |
| Ozempic (type 2 diabetes label) | No generic exists | Often $25-$100/month copay with T2D coverage | Insurance route for diabetics only |
| Rybelsus (oral semaglutide, T2D label) | No generic exists | $900-$1,000/month retail without coverage | Rarely the value option for weight loss |
How to Save on Semaglutide
- Check brand coverage before subscribing to anything compounded: covered Wegovy with the savings card beats compounded programs on price and gives you the FDA-approved product.
- Compare compounded programs against the $499 NovoCare benchmark, not against $1,349 retail: the honest savings from a $179 program is $320/month, not $1,170.
- Confirm steady-state pricing: intro rates and lowest-dose pricing understate what month six costs after dose escalation. Ask for the full dose-price schedule in writing.
- Ask what happens to your protocol if compounding rules tighten further: programs with a transition path to branded product protect you from abrupt discontinuation.
- Use HSA/FSA funds for prescribed GLP-1 programs; the pre-tax discount effectively cuts 20-35% off your real cost.
- Do not stack cheap sources: buying research-grade semaglutide from unregulated websites to save money is where the genuine safety failures happen, including products with no active ingredient or wildly wrong concentrations.
Hidden Costs and Risks to Watch For
- Dose escalation pricing: standard titration raises your dose over months, and many programs price higher doses $30-$80 above the advertised starting rate.
- Vial dosing errors: the FDA has received reports of patients drawing multiple times the intended dose from compounded vials; confirm your program provides exact syringe instructions and unit markings for every dose change.
- Pharmacy sourcing opacity: legitimate programs name their partner pharmacy and its state license; treat refusal to identify the pharmacy as disqualifying.
- Cancellation friction: some subscriptions require notice periods or charge restart fees; GLP-1 discontinuation also typically brings appetite and weight rebound, documented in trial extension data.
- Lab work and follow-up visits billed separately at some programs, adding $50-$150 quarterly.
- Regulatory transition risk: the legal lane for compounded semaglutide narrowed after the shortage ended in February 2025 and could narrow again; a program with no branded fallback leaves you managing an abrupt stop alone.
Frequently Asked Questions
How much does compounded semaglutide cost per month?
Telehealth compounded semaglutide programs run $99-$227 per month all-inclusive in 2026, covering the medication, prescriber consultation, and shipping. In our comparison set, Strut Health starts at $99 per month, MEDVi and TrimRx at $179, Sprout Health and SkinnyRx at $199, and MyStart Health at $222. Two pricing realities to check before subscribing: first, advertised rates usually reflect the lowest starting dose, and standard titration schedules raise both your dose and often your price within 2-4 months; second, intro pricing for the first month can differ from steady-state cost. The benchmark to compare against is $499 per month for brand-name Wegovy through NovoCare Pharmacy, the manufacturer self-pay channel. A $179 compounded program saves you roughly $320 per month against that benchmark, which is substantial but far smaller than comparisons against the $1,349 retail list price suggest.
Is compounded semaglutide legal in 2026?
It occupies a narrower legal lane than it did during the shortage years. Compounding pharmacies could legally mass-produce copies of Wegovy and Ozempic while the FDA shortage designation was active, but the agency declared the semaglutide shortage resolved in February 2025, and enforcement deadlines for 503A and 503B pharmacies followed within months. What remains legal is traditional compounding: individually prescribed formulations that a prescriber documents as clinically necessary for a specific patient, such as a modified dose or added ingredient. Many telehealth programs operate in that lane today. The practical questions for you are whether a licensed US prescriber evaluates you individually, whether the program names its licensed US pharmacy, and whether the prescription documents patient-specific reasoning. Programs that meet all three are operating within the current framework; sources that skip prescriber involvement entirely are not, and never were.
Is compounded semaglutide as effective as Wegovy?
The active molecule is the same, and semaglutide itself has strong evidence: 14.9% average body weight loss over 68 weeks in the STEP 1 trial published in the New England Journal of Medicine. What compounded products lack is the FDA manufacturing oversight that guarantees each vial contains exactly the labeled concentration. Brand Wegovy pens are produced under pharmaceutical GMP standards with dose-locked injectors; compounded semaglutide depends on the individual pharmacy sourcing pharmaceutical-grade ingredients and preparing them accurately, and quality varies across the industry. The FDA has also received reports of dosing errors with compounded vials, where patients drew several times the intended dose using unfamiliar syringe markings. If your program uses a reputable licensed pharmacy and gives you precise administration instructions, expected outcomes track the semaglutide evidence base. The uncertainty you accept is manufacturing consistency, not whether the molecule works.
Why is compounded semaglutide so much cheaper than Wegovy?
Because you are paying for different things. Brand Wegovy pricing carries the research and development cost of the original clinical trials, patent-protected margins, the autoinjector pen device, and pharmaceutical-scale manufacturing oversight. Compounded semaglutide is prepared by pharmacies from semaglutide active ingredient, skips device costs by shipping vials and syringes, and is sold through telehealth programs competing aggressively on price. None of that markup difference reflects the molecule itself. It is worth knowing that the gap has narrowed: Novo Nordisk introduced the NovoCare self-pay channel at $499 per month partly to compete with compounders, which cut the compounded advantage from over $1,000 per month against retail to $270-$400 against the direct channel. That is why the smarter comparison for your budget is compounded versus NovoCare, and why programs priced near $400 face a hard question about what you are getting for near-brand money.
What should I ask before starting a compounded semaglutide program?
Five questions filter the field quickly. First, which licensed US pharmacy fills the prescription, and in which state? Legitimate programs answer immediately; evasion is disqualifying. Second, what is the full dose-price schedule through month six, including escalation, so the advertised starting price cannot surprise you later. Third, what exact administration instructions and syringe guidance come with each dose change, given documented FDA reports of multi-fold dosing errors with compounded vials. Fourth, what happens to your treatment if compounding rules tighten again, and whether the program offers a transition path to branded product like NovoCare Wegovy at $499 per month. Fifth, who evaluates you clinically, at intake and ongoing, and how fast the provider responds when you report side effects. Any program that answers all five cleanly is treating you as a patient; a program that stumbles on most of them is treating you as a subscription.
Can I use HSA or FSA funds for compounded semaglutide?
Generally yes, when it is prescribed for weight management by a licensed provider. Prescription medications, including compounded preparations, qualify as medical expenses under IRS rules, and the prescriber consultation and related lab work qualify alongside them. Practical execution: pay with your HSA or FSA card where the program accepts it, or pay out of pocket and submit for reimbursement with an itemized receipt showing the prescription, the provider, and the amounts. Most established telehealth programs generate HSA-formatted receipts on request because the question comes up constantly. The pre-tax treatment matters at these price points: a $179 per month program funded through an HSA effectively costs $116-$143 per month depending on your tax bracket, and a $499 NovoCare Wegovy subscription drops to an effective $325-$400. If your employer offers an HSA and you are budgeting for a year of GLP-1 treatment, routing it through pre-tax dollars is the single easiest saving available.
What is the cheapest compounded semaglutide program?
In our tracked comparison set, Strut Health holds the low end at $99 per month with consultation and shipping included, followed by MEDVi and TrimRx at $179, Sprout Health and SkinnyRx at $199, and MyStart Health at $222. Before choosing purely on the headline number, verify three things that change the real ranking. First, the steady-state price after dose escalation, because programs differ in how much higher doses cost and standard titration will move you up within months. Second, what the subscription actually includes: a $99 program that bills labs and follow-ups separately can cost more over six months than a $179 program that includes them. Third, refill flexibility and cancellation terms, since a locked-in commitment at a low monthly rate can exceed a flexible plan you can pause. The cheapest program is the one with the lowest six-month total for your dose, not the lowest first-month banner price.
Why do compounded semaglutide prices vary so much between programs?
The medication itself is a minor share of program cost, which is why prices span $99 to $227 for the same active ingredient. The real variables: which compounding pharmacy the program contracts with and at what volume pricing; how much clinical service is bundled, from bare prescription renewal up to responsive providers, dose management, and side effect support; customer acquisition spending, because programs advertising heavily price that spending into subscriptions; and dose, since higher maintenance doses use more medication and often carry $30-$80 tier premiums. What price does not reliably signal is medication quality. A $99 program and a $227 program may use equally reputable pharmacies, and a mid-priced program may use a weaker one. Judge quality directly: ask which licensed US pharmacy fills the prescription, confirm its state license, and evaluate how the program handled your intake questions. Pay more only for service you will actually use, not for the assumption that expensive means safer.
How much does a year of compounded semaglutide cost?
Annual totals for the programs in our comparison set: roughly $1,200 per year at Strut Health ($99/month), $2,150 at MEDVi or TrimRx ($179/month), $2,400 at Sprout Health or SkinnyRx ($199/month), and $2,650 at MyStart Health ($222/month), before dose escalation premiums that can add $300-$900 depending on your maintenance dose. The branded comparison: NovoCare Wegovy at $499 per month runs $5,988 per year, and covered commercial insurance with the savings card can run a few hundred dollars total. Two things belong in an honest annual budget. First, monitoring: if your program bills labs or follow-up visits separately, add $200-$500. Second, the maintenance reality: STEP trial extension data documents substantial weight regain after discontinuation, so treat GLP-1 treatment as a multi-year commitment when comparing against alternatives like the branded routes or intensive lifestyle programs, not as a single-year expense that simply ends.
Is oral compounded semaglutide cheaper than injectable?
Oral and sublingual compounded semaglutide products typically price in the same $99-$249 monthly range as injectable programs, sometimes slightly higher, so the format choice is not primarily a cost decision. The clinical tradeoff matters more than the price difference. Oral semaglutide absorbs far less efficiently than injection: the FDA-approved oral product Rybelsus uses a specialized absorption enhancer and still delivers a small fraction of an injected dose, and compounded sublingual drops and troches lack the absorption data behind even that product. Published weight loss evidence, including the 14.9% STEP 1 result, comes overwhelmingly from once-weekly subcutaneous injection. If needle aversion is the obstacle, the honest comparison is a compounded sublingual with limited evidence versus an injectable with a 4mm needle most people find far easier than expected. Price them side by side at your dose, but weigh the evidence gap more heavily than a $20-$50 monthly difference in either direction.
Sources & References
Our comparisons are informed by official sources and regulatory guidelines. We encourage readers to verify information with authoritative sources.
- FDA Drug InformationGLP-1 medication approvals and safety
- NIH National Institute of DiabetesWeight management research
- CDC Obesity InformationObesity statistics and health impacts
- Obesity Medicine AssociationClinical obesity treatment guidelines
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
Ready to Compare Providers?
Use our cost calculator to get personalized pricing estimates based on your insurance and location.
Disclaimer: Pricing information is based on publicly available data and may change without notice. Actual costs depend on your specific treatment plan, insurance coverage, and provider. Always verify current pricing with providers before purchasing. This article is for informational purposes only and is not financial or medical advice. We may receive compensation through affiliate links, which helps support our research.